» Articles » PMID: 9557734

Biological Characterization of Rev Variation in Equine Infectious Anemia Virus

Overview
Journal J Virol
Date 1998 Apr 29
PMID 9557734
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Sequence analysis identified significant variation in the second exon of equine infectious anemia virus (EIAV) rev. Functional analysis indicated that limited amino acid variation in Rev significantly altered the export activity of the protein but did not affect Rev-dependent alternative splicing. EIAV Rev can mediate export through two independent cis-acting Rev-responsive elements (RREs), and differences among Rev variants were more pronounced when both RREs were present. Variation in Rev may be an important mechanism for regulation of virus replication in vivo and may contribute to changes in clinical disease.

Citing Articles

Rev-RRE activity modulates HIV-1 replication and latency reactivation: Implications for viral persistence and cure strategies.

Dzhivhuho G, Jackson P, Honeycutt E, da Silva Mesquita F, Huang J, Hammarskjold M bioRxiv. 2025; .

PMID: 39829859 PMC: 11741256. DOI: 10.1101/2025.01.06.631466.


Rev-Rev Response Element Activity Selection Bias at the Human Immunodeficiency Virus Transmission Bottleneck.

Jackson P, Holsey J, Turse L, Hammarskjold M, Rekosh D Open Forum Infect Dis. 2023; 10(10):ofad486.

PMID: 37854107 PMC: 10580148. DOI: 10.1093/ofid/ofad486.


Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.

Li J, Zhang X, Bai B, Zhang M, Ma W, Lin Y J Virol. 2022; 96(24):e0121022.

PMID: 36448796 PMC: 9769392. DOI: 10.1128/jvi.01210-22.


SYNJ2BP Improves the Production of Lentiviral Envelope Protein by Facilitating the Formation of Mitochondrion-Associated Endoplasmic Reticulum Membrane.

Duan Y, Wang X, Sun K, Lin Y, Wang X, Chen K J Virol. 2022; 96(20):e0054922.

PMID: 36197105 PMC: 9599250. DOI: 10.1128/jvi.00549-22.


Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.

Sherpa C, Jackson P, Gray L, Anastos K, Le Grice S, Hammarskjold M J Virol. 2019; 93(11).

PMID: 30867301 PMC: 6532081. DOI: 10.1128/JVI.02102-18.


References
1.
Stutz F, Neville M, Rosbash M . Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell. 1995; 82(3):495-506. DOI: 10.1016/0092-8674(95)90438-7. View

2.
Fischer U, Huber J, Boelens W, Mattaj I, Luhrmann R . The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 1995; 82(3):475-83. DOI: 10.1016/0092-8674(95)90436-0. View

3.
Meyer B, Meinkoth J, Malim M . Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J Virol. 1996; 70(4):2350-9. PMC: 190077. DOI: 10.1128/JVI.70.4.2350-2359.1996. View

4.
Gontarek R, Derse D . Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol Cell Biol. 1996; 16(5):2325-31. PMC: 231220. DOI: 10.1128/MCB.16.5.2325. View

5.
Fridell R, Bogerd H, Cullen B . Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc Natl Acad Sci U S A. 1996; 93(9):4421-4. PMC: 39553. DOI: 10.1073/pnas.93.9.4421. View